Perceptive Capital Solutions Corp
PCSCCIK 0002017526 · Services-Medical Laboratories · Nasdaq
Revenue (TTM)
—
Mar 2026
Net Income (TTM)
$1.53M
−56.2% YoY
Mar 2026
EPS Diluted (TTM)
—
Mar 2026
Gross Margin
—
Mar 2026
Operating Margin
—
Mar 2026
Net Margin
—
Mar 2026
Free Cash Flow (TTM)
—
Mar 2026
Cash
$567.18K
Mar 2026
Total Debt
—
Mar 2026
Shares Outstanding
8.91M sh
Mar 2026
Revenue & Net Income
Cash Flow
Revenue Growth (YoY)
No data available for this metric.